Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 13;18(10):e0292899.
doi: 10.1371/journal.pone.0292899. eCollection 2023.

Retrospective cohort analysis of outpatient antibiotic prescribing for community-acquired pneumonia in Canadian older adults

Ariana Saatchi  1 , Jennifer N Reid  2 , Salimah Z Shariff  2 , Marcus Povitz  3 , Michael Silverman  4 , David M Patrick  5   6 , Andrew M Morris  7 , James McCormack  1 , Manon R Haverkate  1 , Fawziah Marra  1
Affiliations

Retrospective cohort analysis of outpatient antibiotic prescribing for community-acquired pneumonia in Canadian older adults

Ariana Saatchi et al. PLoS One. .

Abstract

Background: This retrospective cohort study is the first in North America to examine population-level appropriate antibiotic use for community-acquired pneumonia (CAP) in older adults, by agent, dose and duration. With the highest rates of CAP reported in the elderly populations, appropriate antibiotic use is essential to improve clinical outcomes. Given the ongoing crisis of antimicrobial resistance, understanding inappropriate antibiotic prescribing is integral to direct community stewardship efforts.

Methods: All outpatient primary care visits for CAP (aged ≥65 years) were identified using physician billing codes between January 1 2014 to December 31 2018 in British Columbia (BC) and Ontario (ON). Categories of prescribing were derived from existing literature, and constructed for clinical relevance using Canadian and international guidelines available during the study period. Categories were mutually exclusive and included: guideline adherent (first-line agent, adherent dose/duration), clinically appropriate (non-first line agent, presence of comorbidities), effective but unnecessary (first-line agent, excess dose/duration), undertreatment (first-line agent, subtherapeutic dose/duration), and not recommended (non-first line agent, absence of comorbidities). Proportions of prescribing were examined by category. Temporal trends in prescribing were examined using Poisson regression.

Results: A total of 436,441 episodes of CAP were identified, with 46% prescribed an antibiotic in BC, and 52% in Ontario. Guideline adherent prescribing was minimal for both provinces (BC: 2%; ON: 1%) however the largest magnitude of increase was reported in this category by the final study year (BC-Rate Ratio [RR]: 3.4, 95% Confidence Interval [CI]: 2.7-4.3; ON-RR: 4.62, 95% CI: 3.4-6.5). Clinically appropriate prescribing accounted for the most antibiotics issued, across all study years (BC: 61%; ON: 74%) (BC-RR: 0.8, 95% CI: 0.8-0.8; ON-RR: 0.9, 95% CI: 0.8-0.9). Excess duration of therapy was the hallmark characteristic for effective but unnecessary prescribing (BC: 92%; ON: 99%). The most common duration prescribed was 7 days, followed by 10. Not recommended prescribing was minimal in both provinces (BC: 4%; ON: 7%) and remained stable by the final study year (BC-RR: 1.1, 95% CI: 0.9-1.2; ON-RR: 0.9, 95% CI: 0.9-1.1).

Conclusion: Three quarters of antibiotic prescribing for CAP was appropriate in Ontario, but only two thirds in BC. Shortening durations-in line with evidence for 3 to 5-day treatment presents a focused target for stewardship efforts.

PubMed Disclaimer

Conflict of interest statement

The authors have declared no competing interests exist.

Figures

Fig 1
Fig 1. Counts of CAP episodes, prescribed episodes and unique patients.
Fig 2
Fig 2. Percentage of outpatient antibiotic prescribing for CAP, by category of prescription quality and year.
Fig 3
Fig 3. Rate of overall antibiotic prescribing for outpatient CAP in Canadian seniors, by age category and province.
See this image and copyright information in PMC

References

    1. S. Jain et al., “Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults,” 10.1056/NEJMoa1500245. Accessed: Apr. 29, 2021. [Online]. https://www.nejm.org/doi/10.1056/NEJMoa1500245 - DOI - DOI
    1. Musher D. M., Abers M. S., and Bartlett J. G., “Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus,” Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., vol. 65, no. 10, pp. 1736–1744, Nov. 2017, doi: 10.1093/cid/cix549 - DOI - PMC - PubMed
    1. Musher D. M., Roig I. L., Cazares G., Stager C. E., Logan N., and Safar H., “Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: Results of a one-year study,” J. Infect., vol. 67, no. 1, pp. 11–18, Jul. 2013, doi: 10.1016/j.jinf.2013.03.003 - DOI - PMC - PubMed
    1. Johansson N., Kalin M., Tiveljung-Lindell A., Giske C. G., and Hedlund J., “Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods,” Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., vol. 50, no. 2, pp. 202–209, Jan. 2010, doi: 10.1086/648678 - DOI - PMC - PubMed
    1. Chen H., Hara Y., Horita N., Saigusa Y., Hirai Y., and Kaneko T., “Declined Functional Status Prolonged Hospital Stay for Community-Acquired Pneumonia in Seniors,” Clin. Interv. Aging, vol. 15, pp. 1513–1519, Aug. 2020, doi: 10.2147/CIA.S267349 - DOI - PMC - PubMed

Publication types

Substances

Grants and funding